Presentation Summary : Title: The RNAi mechanism Author: Trial User Last modified by: Brijesh Krishnaswami Created Date: 11/9/2004 4:21:06 AM Document presentation format
Source : http://virtualhipster.com/Team1_RNAi_Presentation.ppt
Presentation Summary : RNAi doesn’t always work Therapeutics More specific than most other therapies. Can be used to target many cell and tissue types. Efficiently transfers the gene to ...
Source : http://www.biochem.umd.edu/biochem/kahn/teach_res/Posters/RNAi_Fall06.ppt
Presentation Summary : ... sRNAi Benefits — CobaCyte for delivery of RNAi therapeutics represents a breakthrough in the ability to deliver RNAi therapeutics with improved cytotoxic ...
Source : http://www.accesspharma.com/downloads/presentations/ACCP_pres_cowen_2012.ppt
Presentation Summary : High throughput genetics & RNAi Screens Luke Lopas and Mark Devries Silencing Genomes Silencing Genomes How do they analyse RNAi results in other organisms (flys, mice?)
Source : http://gen677.weebly.com/uploads/8/6/5/7/865764/lopasdevriespresentation2-24-09.ppt
Presentation Summary : * * * * * * * * * * * * * * * * * * * SMARTvector RNAi: ... Therapeutics Service / Research Products Service / Research Products Therapeutics Validation ...
Source : http://www3.cancer.gov/bbig/Boro%20Dropulic-%20Adventures%20in%20biotech.pps
Presentation Summary : Chapter 11-Nucleic Acids as Therapeutic Agents Nucleic acids Antisense RNA and oligonucleotides Ribozymes Aptamers, Interfering RNAs or RNAi Gene therapy
Source : http://www.ohio.edu/plantbio/staff/showalte/PBIO%20450%20&%20550/PBIO4500%20Nucleic%20Acid%20Therapeutics.ppt
Presentation Summary : We view these events as starting points for the very significant value that can be created with RNAi therapeutics Indeed, with RNAi therapeutics, ...
Source : http://www.massbio.org/writable/committees/presentations/westphal_talk.ppt
Presentation Summary : ... 2012 FY13 NCI SBIR Contract Topics * Therapeutics & Diagnostics Advancing Cancer Research 313 RNAi Cancer Therapeutics using Nanotechnology 315 Development of ...
Source : http://www.ncbiotech.org/sites/default/files/pages/NCI%20SBIR%20and%20STTR%20Advancing%20the%20Commercialization%20of%20New%20Cancer%20Innovations.ppt
Presentation Summary : Outline History of RNAi Small interfering RNA (siRNA) ... Dorsett, Y and Tuschl, T. siRNAs: applications in functional genomics and potential as therapeutics.
Source : http://instructional1.calstatela.edu/jmomand2/2004/presentations/ppt/lee.ppt
Presentation Summary : RNAi therapeutics developed to harness the siRNA pathway typically involve the delivery of synthetic siRNA into the cell cytoplasm. The microRNA pathway begins with ...
Source : http://dipbsf.uninsubria.it/monti/BFPN%202009/RNAi%202009.ppt
Presentation Summary : The future of antiviral RNAi therapeutics is very ... Tema 9. miRNA & siRNA Discovery of RNAi RNAi was also initially discovered and characterized in the ...
Source : http://www.genomica.uaslp.mx/Academia/MedSchool/Tema9.ppt
Presentation Summary : ... Investigator Blais University Chair in Molecular Medicine Director-RNAi Therapeutics Institute Internationally recognized as co-discoverer of RNAi, ...
Source : https://umassmed.edu/uploadedFiles/CTS/Education/mentors.ppt
Presentation Summary : ... to pipeline of anti-infectives for both hospital-based and community-acquired infections $1.9bn Vicuron Pfizer Develop RNAi therapeutics for pandemic influenza.
Source : http://www.taglaw.com/files/Vancouver%20Tuesday/VT%20Biotech%20in%20Europe.ppt
Presentation Summary : Chapter 10-Protein Therapeutics Chapter 11-Nucleic Acids as Therapeutic Agents ... ribozymes, interfering RNAs or RNAi) Gene therapy Stem cells and therapeutic cloning
Source : http://www.ohio.edu/plantbio/staff/showalte/PBIO%20450%20&%20550/PBIO450TherapeuticsLecture09.ppt
Presentation Summary : ... a member of the RNAi ... screens can be useful tools for mining cellular pathways for clues regarding disease states and for the development of therapeutics.
Source : http://stemcellcourse.org/documents/RNAi-102609.ppt
Presentation Summary : Considerations for RNAi ... role miRNA plays in oncology is the formation of several new companies which seek to expand development of miRNA-based therapeutics ...
Source : http://repository.countway.harvard.edu/xmlui/bitstream/handle/10473/4741/MicroRNA%20Analysis.ppt?sequence=1
Presentation Summary : Pharmacology Pharmacogenetics Pharmacogenomics Pharmacoepidemiology Physical science Prevention research Proteomics RNAi ... therapeutics into the ...
Source : http://deainfo.nci.nih.gov/advisory/ncab/149_0209/presentations/945-DuBois.ppt
Presentation Summary : Systems Biology, Cancer Therapeutics, and Personalized Medicine Timothy Kinsella, M.D. Systems biology is the analysis of the interactions among components of a ...
Source : http://www.imagwiki.nibib.nih.gov/mediawiki/images/f/f7/Kinsella.ppt
Presentation Summary : Diagnosis-----Select Therapeutics-----Select Therapeutics-----Select Therapeutics-----Select Therapeutics -----Select ... RNAi. CI-1040. PD-0325901. AZD6244. Antrax. LT.
Source : http://www.patologosdepuertorico.org/Conferencias/Molecular%202009/targeted%20therapy%20-ppt.pptx
Presentation Summary : Has relatively few (4.8K) base pairs so large therapeutics aren’t viable. ... Reduced the total chol. via RNAi-mediated mRNA degradation. Cholesterol Conjugates.
Source : http://faculty.smu.edu/jbuynak/GeneAntisenseTherapyBrooks.pptx
Presentation Summary : Gene-Silencing Therapeutics siRNA DNA enzymes (DNAzymes) ... (RNAi) MicroRNAs (miRNA, miR) Molecular Diagnostics of the Future? MicroRNA (miRNA, ...
Source : http://www.asip.org/about/documents/Sobel-SmallNucleicAcidMolecules.ppt
Presentation Summary : RNA interference (RNAi) Division of Pre-Clinical Innovation (DPI) DPI currently has 300+ ... Therapeutics for Rare and Neglected Diseases (TRND) Program.
Source : http://www.aipla.org/committees/committee_pages/Biotechnology/Committee%20Documents/Committee%20Presentations/2012.Annual/Creative%20Funding%20for%20Drug%20Development/1.%20AIPLA_Panel_Presentation_NIH_-_Edited_Print_Out_VS.pptx